THC Therapeutics Inc. Stock Analysis THCT
THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The firm is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The company can also reduce the bacterial count of cannabis during the drying process. The firm also operates a portfolio of companies in genetics, cultivation, extraction, and distribution as well as specialty real estate and nutrients for commercial and hobby cannabis growers. These companies consist of Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, Shasta Properties Management, and Blue Sky Investments.
Read More THC Therapeutics Inc (THCT) Chart
Key Statistics of THC Therapeutics Inc (THCT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1238.00P/E Ratio (TTM)
-52 Week Range
Market Cap
36.24KAvg. Volume
5408.75Dividend Yield
-Financial Metrics & Statements of THC Therapeutics Inc (THCT)
FAQ's for THC Therapeutics Inc (THCT)
- According to Musaffa’s Shariah screening methodology, THC Therapeutics Inc (THCT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.